Aarti Drugs Ltd
NSE:AARTIDRUGS

Watchlist Manager
Aarti Drugs Ltd Logo
Aarti Drugs Ltd
NSE:AARTIDRUGS
Watchlist
Price: 397.95 INR 0.05% Market Closed
Market Cap: 36.3B INR

Aarti Drugs Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Aarti Drugs Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Aarti Drugs Ltd
NSE:AARTIDRUGS
Operating Income
₹2.5B
CAGR 3-Years
-2%
CAGR 5-Years
-6%
CAGR 10-Years
6%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Income
₹67.3B
CAGR 3-Years
18%
CAGR 5-Years
16%
CAGR 10-Years
15%
Cipla Ltd
NSE:CIPLA
Operating Income
₹60.6B
CAGR 3-Years
22%
CAGR 5-Years
20%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Income
₹130.6B
CAGR 3-Years
16%
CAGR 5-Years
20%
CAGR 10-Years
9%
Lupin Ltd
NSE:LUPIN
Operating Income
₹51.6B
CAGR 3-Years
168%
CAGR 5-Years
35%
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Income
₹31.9B
CAGR 3-Years
20%
CAGR 5-Years
13%
CAGR 10-Years
6%
No Stocks Found

Aarti Drugs Ltd
Glance View

Market Cap
36.3B INR
Industry
Pharmaceuticals

Aarti Drugs Ltd. engages in the development, manufacture and market of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 1,450 full-time employees. The Company, through its wholly-owned subsidiary Pinnacle Life Science Private Limited, is focused on producing formulations. The Company’s products under APIs include Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole and Ofloxacin. Its pharma intermediates products are Tinidazole, Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide and Raloxifene. The company also offers specialty chemicals, such as Benzene Sulphonyl Chloride and Methyl Nicotinate. The Company’s products under development include Alcoholism Treatment, Anticoagulant, Antihyperphosphatemia, Anti-cholestrol, Cardiovascular, Cardiprotectant and Antidiabetic.

AARTIDRUGS Intrinsic Value
HIDDEN
Show

See Also

What is Aarti Drugs Ltd's Operating Income?
Operating Income
2.5B INR

Based on the financial report for Sep 30, 2025, Aarti Drugs Ltd's Operating Income amounts to 2.5B INR.

What is Aarti Drugs Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
6%

Over the last year, the Operating Income growth was 8%. The average annual Operating Income growth rates for Aarti Drugs Ltd have been -2% over the past three years , -6% over the past five years , and 6% over the past ten years .

Back to Top